Cullinan Oncology LLC
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -77 | -76 | -77 | -80 |
EBITDA | -49,950 | -42,913 | -45,408 | -44,283 |
EBIT | -50,027 | -42,989 | -45,485 | -44,363 |
Net Income | -42,028 | -37,148 | -23,803 | -39,183 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -36,291 | -38,247 | -18,131 | -34,141 |
Cash | 115,021 | 74,228 | 98,434 | 64,847 |
Basic Shares | 55,052 | 43,011 | 42,794 | 42,734 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $18,943 | $18,943 |
Gross Profit | -310 | -93 | 18,943 | -62 |
EBITDA | -190,339 | -408,922 | -67,901 | -60,273 |
EBIT | -190,649 | -409,015 | -67,954 | -60,335 |
Net Income | -153,162 | 111,214 | -65,040 | -50,849 |
Net Change In Cash | 0 | 0 | 18,943 | 18,943 |
Cost of Revenue | 96,378 | -108,424 | ||
Free Cash Flow | -134,483 | -127,797 | -44,022 | -29,782 |
Cash | 98,434 | 550,118 | 430,863 | 168,198 |
Basic Shares | 41,550 | 46,640 | 44,292 | 43,516 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.75 |
2024-03-31 | -$0.86 |
2023-12-31 | -$0.54 |
2023-09-30 | -$0.91 |
